S2A Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 24, 1996
February 4, 2025
ca49b04b-b2c6-46ef-b611-f5fbdfa7f55f
Related Documents
Q5B Quality of Biotechnological Products: Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products
Guidance DocumentFebruary 23, 1996Center for Drug Evaluation and Research
S1A The Need for Long-term Rodent Carcinogenicity Studies of Pharmaceuticals
Guidance DocumentMarch 1, 1996Center for Drug Evaluation and Research
Q5C Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products
Guidance DocumentJuly 1, 1996Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.